KIMBERLY SUTTON: Open Payments
NPI 1720547359 · TEXARKANA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,434 in 51 payments from 12 companies in 2025. Trend: 2023 $1,182 · 2024 $1,372 · 2025 $1,434
Food & beverage: $1,340Education: $95
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $419 |
| Actelion Pharmaceuticals US, Inc. | 7 | $361 |
| Regeneron Healthcare Solutions, Inc. | 12 | $309 |
| United Therapeutics Corporation | 3 | $85 |
| Verona Pharma, Inc. | 4 | $68 |
| GlaxoSmithKline, LLC. | 3 | $58 |
| Viatris Specialty LLC | 1 | $34 |
| Insmed, Inc. | 2 | $30 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| Amgen Inc. | 1 | $17 |
Products named: DUPIXENT, UPTRAVI, TEZSPIRE, BREZTRI, FASENRA, Tyvaso, OPSUMIT, Ohtuvayre.
Industry payments across TX — which companies pay providers there.
